9 completed, 1 active not recruiting, 1 recruiting, 1 terminated. 13 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 13 | Completed 9, Active not recruiting 1, Recruiting 1, Terminated 1, Unknown 1 |
Follow Obesity, Abdominal: new trials by email Literature Review of Obesity, Abdominal trials Research Report on Obesity, Abdominal
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Berberine on Preventing Cardiovascular Disease and Diabetes Mellitus Berberine plus lifestyle intervention, Placebo plus lifestyle intervention - PreDiabetes, Abdominal Obesity | Phase 4 | Active not recruiting | China National Center for Cardiovascular Diseases | 2024 | 2023-10-31 | 2025-12-31 |
| Effects of Berberine in Reducing Abdominal Visceral Adipose Tissue Among Individuals with Obesity and NAFLD Berberine plus lifestyle intervention, Placebo plus lifestyle intervention - Obesity, Obesity, Abdominal | Phase 4 | Completed | China National Center for Cardiovascular Diseases | 337 | 2023-07-06 | 2025-01-29 |
| Bioenergetic Effects of Aging and Menopause (BEAM) GnRH antagonist, Estrogen Product, Placebo estradiol - Menopause, Obesity, Abdominal | Phase 4 | Recruiting | University of Colorado, Denver | 57 | 2019-09-24 | 2023-12-18 |
| Impact of Liraglutide 3.0 on Body Fat Distribution Liraglutide, Placebo - Obesity, Visceral, Cardiovascular Diseases | Phase 4 | Completed | University of Texas Southwestern Medical Center | 235 | 2017-01-01 | 2021-11-19 |
| Genomic Outcomes of Metformin Metformin, Placebo - Coronary Artery Disease, Mild Cognitive Impairment | Phase 4 | Completed | Wake Forest University Health Sciences | 30 | 2016-08-03 | 2023-11-18 |
| Visceral Adiposity and Diabetes: Translating Form to Function Using Imaging [U-13C3] glycerol, Empagliflozin, Placebo (for Empagliflozin) - Obesity, Visceral | Phase 4 | Completed | University of Texas Southwestern Medical Center | 40 | 2016-03-01 | 2020-01-23 |
| Study on Effects of Testosterone Replacement Therapy in Hypogonadal Type 2 Diabetic Patients" (SETH2) Testosterone Undecanoate, Placebo - Hypogonadism, Male, Diabetes Mellitus, Type 2 | Phase 4 | Completed | University Medical Centre Ljubljana | 55 | 2014-01-10 | 2019-01-04 |
| The Effect of Moxonidine on Blood Pressure and Regression of Early Target Organ Damage in Young Subjects With Abdominal Obesity and Hypertension Moxonidine, Irbesartan - Abdominal Obesity, Hypertension | Phase 4 | Unknown | Baker Heart and Diabetes Institute | 100 | 2012-01-01 | 2012-02-03 |
| Treatment of Adiposity Related hypErTension (TARGET) Aliskiren, Moxonidine, Hydrochlorothiazide - Hypertension, Abdominal Obesity | Phase 4 | Completed | UMC Utrecht | 32 | 2010-08-01 | 2012-02-24 |
| Trial Comparing Metabolic Effects of Telmisartan and Amlodipine on Hypertensive Patients With Obesity and Diabetes Temisartan, Amlodipine - Hypertension, Obesity | Phase 4 | Completed | Third Military Medical University | 120 | 2008-06-01 | 2013-12-17 |
| A Randomized, Double-Blind, Active Control Trial Comparing Effects of Telmisartan, Candesartan and Amlodipine, Alone or Plus Metformin, on Non-Diabetic, Obese Hypertensive Patients Telmisartan plus Metformin, Telmisartan, Candesartan - Hypertension, Obesity | Phase 4 | Completed | Third Military Medical University | 360 | 2008-02-01 | 2013-05-14 |
| Metabolic Effects of Antihypertensive Drugs on People With Metabolic Syndrome (The MEAD Study) Hydrochlorothiazide, Trandolapril - Hypertension | Phase 4 | Completed | University of Florida | 24 | 2007-05-01 | 2014-06-17 |
| Clinical Trial to Assess the Effects of Candesartan on the Carbohydrate Metabolism of Obese Subjects Candesartan, Placebo - Glucose Intolerance, Obesity | Phase 4 | Terminated | Fundación Cardiovascular de Colombia | 56 | 2006-06-01 | 2012-11-06 |
Obesity (8) · Hypertension (7) · Diabetes Mellitus (3) · Metabolic Syndrome (3) · Glucose Intolerance (2) · Non-alcoholic Fatty Liver Disease (2) · Atherosclerosis (1) · Cardiovascular Diseases (1) · Cognitive Dysfunction (1) · Coronary Artery Disease (1) · Depression (1) · Diabetes Mellitus, Type 2 (1) · Dyslipidemias (1) · Eunuchism (1)
Body Weight (13) · Nutrition Disorders (13) · Nutritional and Metabolic Diseases (13) · Overnutrition (13) · Overweight (13) · Pathological Conditions, Signs and Symptoms (13) · Signs and Symptoms (13) · Metabolic Diseases (8) · Cardiovascular Diseases (7) · Glucose Metabolism Disorders (7) · Vascular Diseases (7) · Obesity (5) · Endocrine System Diseases (4) · Hyperinsulinism (3) · Arterial Occlusive Diseases (2)
Amlodipine (2) · Berberine (2) · Hydrochlorothiazide (2) · Metformin (2) · candesartan (2) · moxonidine (2) · Glycerol (1) · Irbesartan (1) · LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- (1) · Liraglutide (1) · Sodium Chloride (1) · Sugars (1) · Telmisartan (1) · acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide (1) · aliskiren (1)
China National Center for Cardiovascular Diseases (2) · Third Military Medical University (2) · University of Texas Southwestern Medical Center (2) · Baker Heart and Diabetes Institute (1) · Fundación Cardiovascular de Colombia (1) · UMC Utrecht (1) · University Medical Centre Ljubljana (1) · University of Colorado, Denver (1) · University of Florida (1) · Wake Forest University Health Sciences (1)
United States (5) · China (4) · Australia (1) · Colombia (1) · Netherlands (1)
Haibo Zhang, MD (2) · Jing Li, PhD (2) · Zhiming Zhu, MD, PhD (2) · Federico A Silva, MD (1) · Gustavo Marques, MD (1) · Ian Neeland, MD (1) · Jingzhong Ding, PhD (1) · Kristina Groti Antonic, MD, PhD (1) · Parag Joshi, MD (1) · Rhonda M. Cooper-DeHoff, Pharm D, MS (1) · Ronald G Garcia Gomez, MD, PhD (1) · Vicente Lahera, PhD (1) · W. Spiering, MD PhD (1) · Wendy M Kohrt, PhD (1)
PMID 16959033, PMID 22525206, PMID 29085669, PMID 32568464, PMID 34358471, PMID 41543854
K23DK106520 (1), K23HL086558 (1), U54AG062319 (1)